chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Headache, Injection site pain, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: After receiving the vaccine, my arm ached at the injection site for half a day, and I had a headache. I started feeling systems of a sore throat, headache and stuffiness on 12/11/2022. On 12/14/2022, I tested positive for COVID-19 at a testing center. I contacted my doctor that day and got a prescription for PAXLOVID.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: After receiving the vaccine, my arm ached at the injection site for half a day, and I had a headache. I started feeling systems of a sore throat, headache and stuffiness on 12/11/2022. On 12/14/2022, I tested positive for COVID-19 at a testing center. I contacted my doctor that day and got a prescription for PAXLOVID.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product use issue
Clinical narrative: Given past 30 day use by date in fridge
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, Asthenia, Atrial fibrillation, Bacterial test
Clinical narrative: Patient is a 78 years Old  female patient of DO with history of CKD 3, HTN, prediabetes, thyroid disease, DDD, and back pain presented to a local Hospital with generalized weakness with nausea and vomiting.Initial CXR revealed  Opacity in the R lung base WBCs 20k. Lactate 1.8.  CRP 176.  PCT 3.15.  COVID +  Blood cultures w/ NGTD.   Urine antigen + pneumococcus ,responded to antibiotic.Hospital course complicated with NSTEMI,A-fib,initially managed with Cardizem drip,subsequent TEE/cardioversion with restoration of NSR . Patient is now stable cleared for discharge.   Discharge Diagnoses: Community acquired pneumonia  Covid-19 pneumonia  Severe sepsis, POA. AF w/ RVR   NSTEMI, suspected type 2 Acute kidney injury Hypokalemia. Chronic normocytic anemia  Hypertension Essential  Obesity; BMI 34.13
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture negative, Blood lactic acid, C-reactive protein increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 78 years Old  female patient of DO with history of CKD 3, HTN, prediabetes, thyroid disease, DDD, and back pain presented to a local Hospital with generalized weakness with nausea and vomiting.Initial CXR revealed  Opacity in the R lung base WBCs 20k. Lactate 1.8.  CRP 176.  PCT 3.15.  COVID +  Blood cultures w/ NGTD.   Urine antigen + pneumococcus ,responded to antibiotic.Hospital course complicated with NSTEMI,A-fib,initially managed with Cardizem drip,subsequent TEE/cardioversion with restoration of NSR . Patient is now stable cleared for discharge.   Discharge Diagnoses: Community acquired pneumonia  Covid-19 pneumonia  Severe sepsis, POA. AF w/ RVR   NSTEMI, suspected type 2 Acute kidney injury Hypokalemia. Chronic normocytic anemia  Hypertension Essential  Obesity; BMI 34.13
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cardioversion, Chest X-ray abnormal, Echocardiogram, Essential hypertension, Hypokalaemia
Clinical narrative: Patient is a 78 years Old  female patient of DO with history of CKD 3, HTN, prediabetes, thyroid disease, DDD, and back pain presented to a local Hospital with generalized weakness with nausea and vomiting.Initial CXR revealed  Opacity in the R lung base WBCs 20k. Lactate 1.8.  CRP 176.  PCT 3.15.  COVID +  Blood cultures w/ NGTD.   Urine antigen + pneumococcus ,responded to antibiotic.Hospital course complicated with NSTEMI,A-fib,initially managed with Cardizem drip,subsequent TEE/cardioversion with restoration of NSR . Patient is now stable cleared for discharge.   Discharge Diagnoses: Community acquired pneumonia  Covid-19 pneumonia  Severe sepsis, POA. AF w/ RVR   NSTEMI, suspected type 2 Acute kidney injury Hypokalemia. Chronic normocytic anemia  Hypertension Essential  Obesity; BMI 34.13
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Nausea, Normocytic anaemia, Obesity, Pneumonia
Clinical narrative: Patient is a 78 years Old  female patient of DO with history of CKD 3, HTN, prediabetes, thyroid disease, DDD, and back pain presented to a local Hospital with generalized weakness with nausea and vomiting.Initial CXR revealed  Opacity in the R lung base WBCs 20k. Lactate 1.8.  CRP 176.  PCT 3.15.  COVID +  Blood cultures w/ NGTD.   Urine antigen + pneumococcus ,responded to antibiotic.Hospital course complicated with NSTEMI,A-fib,initially managed with Cardizem drip,subsequent TEE/cardioversion with restoration of NSR . Patient is now stable cleared for discharge.   Discharge Diagnoses: Community acquired pneumonia  Covid-19 pneumonia  Severe sepsis, POA. AF w/ RVR   NSTEMI, suspected type 2 Acute kidney injury Hypokalemia. Chronic normocytic anemia  Hypertension Essential  Obesity; BMI 34.13
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Procalcitonin, SARS-CoV-2 test positive, Sepsis, Urine antigen test, Vomiting
Clinical narrative: Patient is a 78 years Old  female patient of DO with history of CKD 3, HTN, prediabetes, thyroid disease, DDD, and back pain presented to a local Hospital with generalized weakness with nausea and vomiting.Initial CXR revealed  Opacity in the R lung base WBCs 20k. Lactate 1.8.  CRP 176.  PCT 3.15.  COVID +  Blood cultures w/ NGTD.   Urine antigen + pneumococcus ,responded to antibiotic.Hospital course complicated with NSTEMI,A-fib,initially managed with Cardizem drip,subsequent TEE/cardioversion with restoration of NSR . Patient is now stable cleared for discharge.   Discharge Diagnoses: Community acquired pneumonia  Covid-19 pneumonia  Severe sepsis, POA. AF w/ RVR   NSTEMI, suspected type 2 Acute kidney injury Hypokalemia. Chronic normocytic anemia  Hypertension Essential  Obesity; BMI 34.13
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient is a 78 years Old  female patient of DO with history of CKD 3, HTN, prediabetes, thyroid disease, DDD, and back pain presented to a local Hospital with generalized weakness with nausea and vomiting.Initial CXR revealed  Opacity in the R lung base WBCs 20k. Lactate 1.8.  CRP 176.  PCT 3.15.  COVID +  Blood cultures w/ NGTD.   Urine antigen + pneumococcus ,responded to antibiotic.Hospital course complicated with NSTEMI,A-fib,initially managed with Cardizem drip,subsequent TEE/cardioversion with restoration of NSR . Patient is now stable cleared for discharge.   Discharge Diagnoses: Community acquired pneumonia  Covid-19 pneumonia  Severe sepsis, POA. AF w/ RVR   NSTEMI, suspected type 2 Acute kidney injury Hypokalemia. Chronic normocytic anemia  Hypertension Essential  Obesity; BMI 34.13
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The patient should have gotten the bivalent.  I contacted her mother to explain the error, that she got another monovalent.  I enquired if the child is experiencing any adverse reactions such as apprehension, flushing and or skin edema, palpitations, numbness or tingling, itching, localized or generalized urticaria (rash, welts), seizure activity, choking sensation, any coughing, hoarseness or wheezing, difficulty breathing, nausea and vomiting, severe hypotension, vasomotor collapse or loss of consciousness to which mom responded no.  Mom states she is feeling fine.  Mom is encouraged to continue to monitor the patient for any of the above signs and symptoms and to notify the clinic or 911 for any of the above s/s.  Understanding verbalized.  Mom is further advised to bring the child back in 2 months for the pfizer bivalent vaccine understanding also verbalized.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Feeling abnormal, Hyposmia
Clinical narrative: 12/17/22 that evening I started to feel tired. I felt it was from a surgery I had recently had. By 7:30 that night, I was so tired, I felt I was going to fall down and cry. I had to go to bed earlier than normal. I had horrible fatigue. Going into the next day, I developed a postnasal drip. I took a home COVID test and it was negative. For the remainder of the day, I remained tired with postnasal drip. That evening into the next day, I woke up and I was shaking. I could tell I had fever, but could not get up to take it. I fell back asleep and when I woke up, I felt better. I took my temperature, and it was 102.2. I had a little bit of a cough and runny nose. I took a home COVID test and it was positive. I tried to stay hydrated and did not take anything for the fever because it did not feel as high. I called my doctor and he did not consider me high risk and said if I wanted to wait, I had until day 5. So I decided to wait until day 5 to decide about prescribing any medications. On 12/21/22, I felt better. On 12/22/22 I had a cough that was more bronchial.  I contacted my doctor and she prescribed PAXLOVID. I started the PAXLOVID on 12/23/22 in the morning. I finished the PAXLOVID on 12/27/22. The fatigue has not returned. I have a minimal cough. Before I had COVID I had Costochondritis and it flared up again for the past 3 days. All the symptoms of COVID are minimal. I realized the other day when I was cooking, my smell had not gone away, but the smell was like it was far away.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Malaise, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Tremor
Clinical narrative: 12/17/22 that evening I started to feel tired. I felt it was from a surgery I had recently had. By 7:30 that night, I was so tired, I felt I was going to fall down and cry. I had to go to bed earlier than normal. I had horrible fatigue. Going into the next day, I developed a postnasal drip. I took a home COVID test and it was negative. For the remainder of the day, I remained tired with postnasal drip. That evening into the next day, I woke up and I was shaking. I could tell I had fever, but could not get up to take it. I fell back asleep and when I woke up, I felt better. I took my temperature, and it was 102.2. I had a little bit of a cough and runny nose. I took a home COVID test and it was positive. I tried to stay hydrated and did not take anything for the fever because it did not feel as high. I called my doctor and he did not consider me high risk and said if I wanted to wait, I had until day 5. So I decided to wait until day 5 to decide about prescribing any medications. On 12/21/22, I felt better. On 12/22/22 I had a cough that was more bronchial.  I contacted my doctor and she prescribed PAXLOVID. I started the PAXLOVID on 12/23/22 in the morning. I finished the PAXLOVID on 12/27/22. The fatigue has not returned. I have a minimal cough. Before I had COVID I had Costochondritis and it flared up again for the past 3 days. All the symptoms of COVID are minimal. I realized the other day when I was cooking, my smell had not gone away, but the smell was like it was far away.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Upper-airway cough syndrome
Clinical narrative: 12/17/22 that evening I started to feel tired. I felt it was from a surgery I had recently had. By 7:30 that night, I was so tired, I felt I was going to fall down and cry. I had to go to bed earlier than normal. I had horrible fatigue. Going into the next day, I developed a postnasal drip. I took a home COVID test and it was negative. For the remainder of the day, I remained tired with postnasal drip. That evening into the next day, I woke up and I was shaking. I could tell I had fever, but could not get up to take it. I fell back asleep and when I woke up, I felt better. I took my temperature, and it was 102.2. I had a little bit of a cough and runny nose. I took a home COVID test and it was positive. I tried to stay hydrated and did not take anything for the fever because it did not feel as high. I called my doctor and he did not consider me high risk and said if I wanted to wait, I had until day 5. So I decided to wait until day 5 to decide about prescribing any medications. On 12/21/22, I felt better. On 12/22/22 I had a cough that was more bronchial.  I contacted my doctor and she prescribed PAXLOVID. I started the PAXLOVID on 12/23/22 in the morning. I finished the PAXLOVID on 12/27/22. The fatigue has not returned. I have a minimal cough. Before I had COVID I had Costochondritis and it flared up again for the past 3 days. All the symptoms of COVID are minimal. I realized the other day when I was cooking, my smell had not gone away, but the smell was like it was far away.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Rhinorrhoea, SARS-CoV-2 test negative, Secretion discharge, Throat irritation
Clinical narrative: My upper respiratory infection started on 12/20/2022 in the morning when I woke up around 8:00AM. I had a Sinus drainage. The next few days I had cough, sinus drainage, mucus, throat irritation. I did a home COVID-19 test on 12/22/2022 which was negative. I went to the clinic on 12/26/2022 they gave me a dexamethasone and prednisone 20mg for 2 times daily, and cough syrup 4 times a day. I was also prescribed albuterol on 06/02/2022 which I used along with this medication.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Upper respiratory tract infection
Clinical narrative: My upper respiratory infection started on 12/20/2022 in the morning when I woke up around 8:00AM. I had a Sinus drainage. The next few days I had cough, sinus drainage, mucus, throat irritation. I did a home COVID-19 test on 12/22/2022 which was negative. I went to the clinic on 12/26/2022 they gave me a dexamethasone and prednisone 20mg for 2 times daily, and cough syrup 4 times a day. I was also prescribed albuterol on 06/02/2022 which I used along with this medication.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 1 booster
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given a bivalent vaccine, appropriate for his age, but he should have been given a primary dose/monovalent
Age: 3.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Flumist expired 12/26/2022 and was administered 12/28/2022. No symptoms reported at this time.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Decreased appetite, Fatigue, Hypersomnia
Clinical narrative: On 08/17/22, I started feeling achy, the next day I was still achy and very tired, I tested with a home COVID-19 test but it came back negative. On 08/19/22, I had a fever of 104F but with TYLENOL it was 102F, I did not have an appetite but made myself eat. I had an unproductive cough that made my muscles hurt. I was very tired, slept a lot. I called my doctor, had a telehealth, he prescribed PAXLOVID, that I started immediately. I did start feeling within 48 hours after taking the PAXLOVID, but I did get rebound COVID-19. I do feel better, but I feel that COVID-19 left me some lingering effects, I cannot regulate my body temperature and my vision is off.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia, SARS-CoV-2 test, Temperature regulation disorder
Clinical narrative: On 08/17/22, I started feeling achy, the next day I was still achy and very tired, I tested with a home COVID-19 test but it came back negative. On 08/19/22, I had a fever of 104F but with TYLENOL it was 102F, I did not have an appetite but made myself eat. I had an unproductive cough that made my muscles hurt. I was very tired, slept a lot. I called my doctor, had a telehealth, he prescribed PAXLOVID, that I started immediately. I did start feeling within 48 hours after taking the PAXLOVID, but I did get rebound COVID-19. I do feel better, but I feel that COVID-19 left me some lingering effects, I cannot regulate my body temperature and my vision is off.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: On 08/17/22, I started feeling achy, the next day I was still achy and very tired, I tested with a home COVID-19 test but it came back negative. On 08/19/22, I had a fever of 104F but with TYLENOL it was 102F, I did not have an appetite but made myself eat. I had an unproductive cough that made my muscles hurt. I was very tired, slept a lot. I called my doctor, had a telehealth, he prescribed PAXLOVID, that I started immediately. I did start feeling within 48 hours after taking the PAXLOVID, but I did get rebound COVID-19. I do feel better, but I feel that COVID-19 left me some lingering effects, I cannot regulate my body temperature and my vision is off.
Age: 16.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Asthenia, Dizziness, Immediate post-injection reaction, Trendelenburg position
Clinical narrative: Patient became dizzy and weak immediately after receiving vaccinations.  No loss of consciousness. Patient immediately placed in trendelenburg position.  V/S:  BP 118/66, HR 60 (repeat HR after 3 minutes 70 BPM), R 16 unlabored, SPO2 97% RA.  HOB elevated in 30-degree intervals q 5minutes until patient sitting upright comfortably.  After demonstrating ability to tolerate small sips of water, pt repositioned with legs dangling from exam table, then assisted to standing position.  Able to ambulate without assistance.  Patient monitored for 20 minutes after event, then discharged to his mother.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, C-reactive protein increased, COVID-19 pneumonia, Computerised tomogram thorax abnormal, Dyspnoea
Clinical narrative: Assessment and Plan Patient is a 52 y.o. female patient of PA-C with history of OSA, Chronic hypoxic respiratory failure, OCP, T2DM, HTN, HLD, Depression, fibromyalgia  presented to Hospital with  SOB. Patient left AMA on hospital day 1 shortly after the below note was completed.   Acute on chronic hypoxic respiratory failure COVID19 pneumonia Hx of Cryptogenic organizing pneumonia  OSA, non complaint to CPAP 2 weeks duration of cough with yellowish sputum, myalgia Received J&J COVID vaccine (single dose), no boosters Only on 2L NC at night at home. Currently on 5L via NC CRP 85.1 CT Chest No evidence of acute pulmonary embolism. Scattered new small foci of ground-glass airspace opacity throughout bilateral lungs, could suggest an atypical infectious process or inflammatory pneumonitis IV Decadron 10 mg, Mucinex, Albuteral PRN,  IS, Acapella Monitor on continouse pulse ox, check CRP Follows with Provenzano as an outpatient   8 mm pulmonary nodule in the right middle lobe lung base  Follow up as outpatient with Pulm   T2DM with hyperglycemia Lantis 10 units at bedtime , SSI and accucheck A1c   Chronic opiod depdnance Fibromyalgia Depression Resume suboxone Resume gapapentin, Baclofen and cymbalta  Resume linzess   HFpEF, Chronic PVD Resume home Plavix and statin
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Myalgia, Productive cough, Pulmonary mass, Respiratory failure
Clinical narrative: Assessment and Plan Patient is a 52 y.o. female patient of PA-C with history of OSA, Chronic hypoxic respiratory failure, OCP, T2DM, HTN, HLD, Depression, fibromyalgia  presented to Hospital with  SOB. Patient left AMA on hospital day 1 shortly after the below note was completed.   Acute on chronic hypoxic respiratory failure COVID19 pneumonia Hx of Cryptogenic organizing pneumonia  OSA, non complaint to CPAP 2 weeks duration of cough with yellowish sputum, myalgia Received J&J COVID vaccine (single dose), no boosters Only on 2L NC at night at home. Currently on 5L via NC CRP 85.1 CT Chest No evidence of acute pulmonary embolism. Scattered new small foci of ground-glass airspace opacity throughout bilateral lungs, could suggest an atypical infectious process or inflammatory pneumonitis IV Decadron 10 mg, Mucinex, Albuteral PRN,  IS, Acapella Monitor on continouse pulse ox, check CRP Follows with Provenzano as an outpatient   8 mm pulmonary nodule in the right middle lobe lung base  Follow up as outpatient with Pulm   T2DM with hyperglycemia Lantis 10 units at bedtime , SSI and accucheck A1c   Chronic opiod depdnance Fibromyalgia Depression Resume suboxone Resume gapapentin, Baclofen and cymbalta  Resume linzess   HFpEF, Chronic PVD Resume home Plavix and statin
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum discoloured
Clinical narrative: Assessment and Plan Patient is a 52 y.o. female patient of PA-C with history of OSA, Chronic hypoxic respiratory failure, OCP, T2DM, HTN, HLD, Depression, fibromyalgia  presented to Hospital with  SOB. Patient left AMA on hospital day 1 shortly after the below note was completed.   Acute on chronic hypoxic respiratory failure COVID19 pneumonia Hx of Cryptogenic organizing pneumonia  OSA, non complaint to CPAP 2 weeks duration of cough with yellowish sputum, myalgia Received J&J COVID vaccine (single dose), no boosters Only on 2L NC at night at home. Currently on 5L via NC CRP 85.1 CT Chest No evidence of acute pulmonary embolism. Scattered new small foci of ground-glass airspace opacity throughout bilateral lungs, could suggest an atypical infectious process or inflammatory pneumonitis IV Decadron 10 mg, Mucinex, Albuteral PRN,  IS, Acapella Monitor on continouse pulse ox, check CRP Follows with Provenzano as an outpatient   8 mm pulmonary nodule in the right middle lobe lung base  Follow up as outpatient with Pulm   T2DM with hyperglycemia Lantis 10 units at bedtime , SSI and accucheck A1c   Chronic opiod depdnance Fibromyalgia Depression Resume suboxone Resume gapapentin, Baclofen and cymbalta  Resume linzess   HFpEF, Chronic PVD Resume home Plavix and statin
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Asthma, Blood lactic acid, COVID-19
Clinical narrative: Patient is a 26 y.o. female admitted to the hospital on 12/6/2022 for shortness of breath in the setting of recent positive COVID-19 test. She required supplemental oxygen on admission but was weaned to room air. Her Paxlovid was continued and she was treated for asthma exacerbation as well as vocal cord dysfunction. Her breathing improved with steroids and she was discharged home.    Discharge Diagnosis and Associated Hospital Course   Acute Hypoxemic Respiratory Failure, Resolved - Likely caused by asthma exacerbation in setting of COVID-19, hx of vocal cord dysfunction d/t numerous past intubations - CXR on admission non-acute - Initially noted to be on 6L NC and was weaned to room air with treatment below    Lactic Acidosis Elevated Anion Gap Metabolic Acidosis - likely secondary to albuterol inhaler  - Lactic acid up-trended to 5.9 on 12/8/2022, initially improved and up-trended prior to discharge - CT 12/8 with no acute intraabdominal processes. Stable hepatomegaly. - Strict ER return precautions given    Moderate Asthma Exacerbation Intermittent Asthma - Likely triggered by COVID-19. Patient reports having to use rescue inhaler once a month. Rarely daytime symptoms and no night time awakenings.  - Home regimen includes albuterol 90 mcg PRN, mometasone-formoterol 100-5 mcg/actuation, tiotropium bromide 1.25 mcg/actuation, cetirizine 10 mg IBD (noncompliant), fluticasone (noncompliant) - S/p IV methylprednisolone and transitioned to oral prednisone 4 day taper. Resumed home inhalers    COVID-19 Infection - Symptom start date 12/2/22. Positive test date 12/3/22. Was immunized  - Was started on paxlovid outpatient which was completed during admission    Vocal Cord Dysfunction - Hx of multiple intubations - continue follow-up outpatient    Stable Hepatomegaly - Unclear cause - CTAP on 12/8 revealed a stable hepatomegaly - Recommend follow up with PCP to address  Depression - Continue home zoloft 200mg dose
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Computerised tomogram abdomen abnormal, Condition aggravated, Dyspnoea, Hepatomegaly
Clinical narrative: Patient is a 26 y.o. female admitted to the hospital on 12/6/2022 for shortness of breath in the setting of recent positive COVID-19 test. She required supplemental oxygen on admission but was weaned to room air. Her Paxlovid was continued and she was treated for asthma exacerbation as well as vocal cord dysfunction. Her breathing improved with steroids and she was discharged home.    Discharge Diagnosis and Associated Hospital Course   Acute Hypoxemic Respiratory Failure, Resolved - Likely caused by asthma exacerbation in setting of COVID-19, hx of vocal cord dysfunction d/t numerous past intubations - CXR on admission non-acute - Initially noted to be on 6L NC and was weaned to room air with treatment below    Lactic Acidosis Elevated Anion Gap Metabolic Acidosis - likely secondary to albuterol inhaler  - Lactic acid up-trended to 5.9 on 12/8/2022, initially improved and up-trended prior to discharge - CT 12/8 with no acute intraabdominal processes. Stable hepatomegaly. - Strict ER return precautions given    Moderate Asthma Exacerbation Intermittent Asthma - Likely triggered by COVID-19. Patient reports having to use rescue inhaler once a month. Rarely daytime symptoms and no night time awakenings.  - Home regimen includes albuterol 90 mcg PRN, mometasone-formoterol 100-5 mcg/actuation, tiotropium bromide 1.25 mcg/actuation, cetirizine 10 mg IBD (noncompliant), fluticasone (noncompliant) - S/p IV methylprednisolone and transitioned to oral prednisone 4 day taper. Resumed home inhalers    COVID-19 Infection - Symptom start date 12/2/22. Positive test date 12/3/22. Was immunized  - Was started on paxlovid outpatient which was completed during admission    Vocal Cord Dysfunction - Hx of multiple intubations - continue follow-up outpatient    Stable Hepatomegaly - Unclear cause - CTAP on 12/8 revealed a stable hepatomegaly - Recommend follow up with PCP to address  Depression - Continue home zoloft 200mg dose
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Lactic acidosis, Malaise, Metabolic acidosis, Respiration abnormal, SARS-CoV-2 test positive
Clinical narrative: Patient is a 26 y.o. female admitted to the hospital on 12/6/2022 for shortness of breath in the setting of recent positive COVID-19 test. She required supplemental oxygen on admission but was weaned to room air. Her Paxlovid was continued and she was treated for asthma exacerbation as well as vocal cord dysfunction. Her breathing improved with steroids and she was discharged home.    Discharge Diagnosis and Associated Hospital Course   Acute Hypoxemic Respiratory Failure, Resolved - Likely caused by asthma exacerbation in setting of COVID-19, hx of vocal cord dysfunction d/t numerous past intubations - CXR on admission non-acute - Initially noted to be on 6L NC and was weaned to room air with treatment below    Lactic Acidosis Elevated Anion Gap Metabolic Acidosis - likely secondary to albuterol inhaler  - Lactic acid up-trended to 5.9 on 12/8/2022, initially improved and up-trended prior to discharge - CT 12/8 with no acute intraabdominal processes. Stable hepatomegaly. - Strict ER return precautions given    Moderate Asthma Exacerbation Intermittent Asthma - Likely triggered by COVID-19. Patient reports having to use rescue inhaler once a month. Rarely daytime symptoms and no night time awakenings.  - Home regimen includes albuterol 90 mcg PRN, mometasone-formoterol 100-5 mcg/actuation, tiotropium bromide 1.25 mcg/actuation, cetirizine 10 mg IBD (noncompliant), fluticasone (noncompliant) - S/p IV methylprednisolone and transitioned to oral prednisone 4 day taper. Resumed home inhalers    COVID-19 Infection - Symptom start date 12/2/22. Positive test date 12/3/22. Was immunized  - Was started on paxlovid outpatient which was completed during admission    Vocal Cord Dysfunction - Hx of multiple intubations - continue follow-up outpatient    Stable Hepatomegaly - Unclear cause - CTAP on 12/8 revealed a stable hepatomegaly - Recommend follow up with PCP to address  Depression - Continue home zoloft 200mg dose
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vocal cord dysfunction
Clinical narrative: Patient is a 26 y.o. female admitted to the hospital on 12/6/2022 for shortness of breath in the setting of recent positive COVID-19 test. She required supplemental oxygen on admission but was weaned to room air. Her Paxlovid was continued and she was treated for asthma exacerbation as well as vocal cord dysfunction. Her breathing improved with steroids and she was discharged home.    Discharge Diagnosis and Associated Hospital Course   Acute Hypoxemic Respiratory Failure, Resolved - Likely caused by asthma exacerbation in setting of COVID-19, hx of vocal cord dysfunction d/t numerous past intubations - CXR on admission non-acute - Initially noted to be on 6L NC and was weaned to room air with treatment below    Lactic Acidosis Elevated Anion Gap Metabolic Acidosis - likely secondary to albuterol inhaler  - Lactic acid up-trended to 5.9 on 12/8/2022, initially improved and up-trended prior to discharge - CT 12/8 with no acute intraabdominal processes. Stable hepatomegaly. - Strict ER return precautions given    Moderate Asthma Exacerbation Intermittent Asthma - Likely triggered by COVID-19. Patient reports having to use rescue inhaler once a month. Rarely daytime symptoms and no night time awakenings.  - Home regimen includes albuterol 90 mcg PRN, mometasone-formoterol 100-5 mcg/actuation, tiotropium bromide 1.25 mcg/actuation, cetirizine 10 mg IBD (noncompliant), fluticasone (noncompliant) - S/p IV methylprednisolone and transitioned to oral prednisone 4 day taper. Resumed home inhalers    COVID-19 Infection - Symptom start date 12/2/22. Positive test date 12/3/22. Was immunized  - Was started on paxlovid outpatient which was completed during admission    Vocal Cord Dysfunction - Hx of multiple intubations - continue follow-up outpatient    Stable Hepatomegaly - Unclear cause - CTAP on 12/8 revealed a stable hepatomegaly - Recommend follow up with PCP to address  Depression - Continue home zoloft 200mg dose
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Admitted on 12/21/22. Transferred to Hospital on 12/28/22 for transitional care stay.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anaemia, Anticoagulant therapy, Anticoagulation drug level above therapeutic, Asthenia, Atelectasis
Clinical narrative: Patient is a 77 y.o. female patient of DO with history of small cell lung cancer on chemotherapy, hyperlipidemia, COPD, hypertension, hypothyroidism, neuropathy and Afib presented to Hospital with generalized weakness and cough.   Generalized weakness S/p Fall  Multifactorial from ongoing cancer chemotherapy (last tx 3 weeks ago) and COVID-19 infection. Having some falls at home Doubt bacterial PNA, but continue antibiotics for now  Had a fall OOB 12/3; no LOC or significant injuries sustained and exam non focal.  Treated with mIVF; encourage adequate PO intake  Consulted PT/OT Doing well 12/6-7 AM   Covid-19 Virus Infection Abnormal CXR, possible CAP Respiratory insufficiency  Date of onset of symptoms: unclear; baseline chronic cough, generalized weakness for 1-2 weeks Symptoms present on admission: Weakness, chronic cough w/ clear phlegm Date of covid positive test: 12/3/22 Vaccination status: vaccinated Imaging: CXR w/ left lung base patchy infiltrate possible pneumonia vs atelectasis  Oxygen requirements on admission: None-- >2L Current oxygen requirements: stable on room air Medical therapy: dexamethasone given 12/3; unclear onset of symptoms, holding remdesivir; continue ceftriaxone/azithromycin for now  Consultants following: e-consult ID to eval for Paxlovid - not a candidate Anticipated special isolation end date: 12/13/2022 U Ag negative; S Cx negative  Wean O2 goal 88-92% Encourage IS/PEP, mucolytics PRN   SCLC w/ mets to adrenals and brain SCLC diagnosed in 12/2021, treated with chemoradiation (carboplatin/etoposide) S/p whole brain radiation in September, currently on lubrinectedin every 3 weeks, due for cycle 3 on 12/5/22 Follows w/ Dr - consulted    COPD Tobacco use Not in acute exacerbation. Recently quit smoking Resume home Spiriva, BD PRN NRT offered, patient declined   Chemotherapy induced peripheral neuropathy Continue gabapentin and B12    Supratherapeutic INR - resolved Hold warfarin, check INR daily INR currently 1.9;   Atrial fibrillation INR 1.9, can resume warfarin per pharmacy Continue metoprolol Elevated BNP likely secondary to Afib than CHF (clinically hypo or euvolemic) Pharmacy to dose warfarin, daily INR  Coumadin managed by PMC AC clinic   HLD Cont statin   Hypothyroidism Cont Synthroid   HTN Resume clonidine and metoprolol   Anemia  Thrombocytopenia Chronic, stable, due to chemotherapy Stable iron and B12 studies in the past Will trend lab   Severe malnutrition poa Nutrition consulted
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Brain natriuretic peptide increased, COVID-19, Chemotherapy, Chest X-ray abnormal, Culture negative
Clinical narrative: Patient is a 77 y.o. female patient of DO with history of small cell lung cancer on chemotherapy, hyperlipidemia, COPD, hypertension, hypothyroidism, neuropathy and Afib presented to Hospital with generalized weakness and cough.   Generalized weakness S/p Fall  Multifactorial from ongoing cancer chemotherapy (last tx 3 weeks ago) and COVID-19 infection. Having some falls at home Doubt bacterial PNA, but continue antibiotics for now  Had a fall OOB 12/3; no LOC or significant injuries sustained and exam non focal.  Treated with mIVF; encourage adequate PO intake  Consulted PT/OT Doing well 12/6-7 AM   Covid-19 Virus Infection Abnormal CXR, possible CAP Respiratory insufficiency  Date of onset of symptoms: unclear; baseline chronic cough, generalized weakness for 1-2 weeks Symptoms present on admission: Weakness, chronic cough w/ clear phlegm Date of covid positive test: 12/3/22 Vaccination status: vaccinated Imaging: CXR w/ left lung base patchy infiltrate possible pneumonia vs atelectasis  Oxygen requirements on admission: None-- >2L Current oxygen requirements: stable on room air Medical therapy: dexamethasone given 12/3; unclear onset of symptoms, holding remdesivir; continue ceftriaxone/azithromycin for now  Consultants following: e-consult ID to eval for Paxlovid - not a candidate Anticipated special isolation end date: 12/13/2022 U Ag negative; S Cx negative  Wean O2 goal 88-92% Encourage IS/PEP, mucolytics PRN   SCLC w/ mets to adrenals and brain SCLC diagnosed in 12/2021, treated with chemoradiation (carboplatin/etoposide) S/p whole brain radiation in September, currently on lubrinectedin every 3 weeks, due for cycle 3 on 12/5/22 Follows w/ Dr - consulted    COPD Tobacco use Not in acute exacerbation. Recently quit smoking Resume home Spiriva, BD PRN NRT offered, patient declined   Chemotherapy induced peripheral neuropathy Continue gabapentin and B12    Supratherapeutic INR - resolved Hold warfarin, check INR daily INR currently 1.9;   Atrial fibrillation INR 1.9, can resume warfarin per pharmacy Continue metoprolol Elevated BNP likely secondary to Afib than CHF (clinically hypo or euvolemic) Pharmacy to dose warfarin, daily INR  Coumadin managed by PMC AC clinic   HLD Cont statin   Hypothyroidism Cont Synthroid   HTN Resume clonidine and metoprolol   Anemia  Thrombocytopenia Chronic, stable, due to chemotherapy Stable iron and B12 studies in the past Will trend lab   Severe malnutrition poa Nutrition consulted
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fall, International normalised ratio increased, Lung infiltration, Malnutrition, Pneumonia
Clinical narrative: Patient is a 77 y.o. female patient of DO with history of small cell lung cancer on chemotherapy, hyperlipidemia, COPD, hypertension, hypothyroidism, neuropathy and Afib presented to Hospital with generalized weakness and cough.   Generalized weakness S/p Fall  Multifactorial from ongoing cancer chemotherapy (last tx 3 weeks ago) and COVID-19 infection. Having some falls at home Doubt bacterial PNA, but continue antibiotics for now  Had a fall OOB 12/3; no LOC or significant injuries sustained and exam non focal.  Treated with mIVF; encourage adequate PO intake  Consulted PT/OT Doing well 12/6-7 AM   Covid-19 Virus Infection Abnormal CXR, possible CAP Respiratory insufficiency  Date of onset of symptoms: unclear; baseline chronic cough, generalized weakness for 1-2 weeks Symptoms present on admission: Weakness, chronic cough w/ clear phlegm Date of covid positive test: 12/3/22 Vaccination status: vaccinated Imaging: CXR w/ left lung base patchy infiltrate possible pneumonia vs atelectasis  Oxygen requirements on admission: None-- >2L Current oxygen requirements: stable on room air Medical therapy: dexamethasone given 12/3; unclear onset of symptoms, holding remdesivir; continue ceftriaxone/azithromycin for now  Consultants following: e-consult ID to eval for Paxlovid - not a candidate Anticipated special isolation end date: 12/13/2022 U Ag negative; S Cx negative  Wean O2 goal 88-92% Encourage IS/PEP, mucolytics PRN   SCLC w/ mets to adrenals and brain SCLC diagnosed in 12/2021, treated with chemoradiation (carboplatin/etoposide) S/p whole brain radiation in September, currently on lubrinectedin every 3 weeks, due for cycle 3 on 12/5/22 Follows w/ Dr - consulted    COPD Tobacco use Not in acute exacerbation. Recently quit smoking Resume home Spiriva, BD PRN NRT offered, patient declined   Chemotherapy induced peripheral neuropathy Continue gabapentin and B12    Supratherapeutic INR - resolved Hold warfarin, check INR daily INR currently 1.9;   Atrial fibrillation INR 1.9, can resume warfarin per pharmacy Continue metoprolol Elevated BNP likely secondary to Afib than CHF (clinically hypo or euvolemic) Pharmacy to dose warfarin, daily INR  Coumadin managed by PMC AC clinic   HLD Cont statin   Hypothyroidism Cont Synthroid   HTN Resume clonidine and metoprolol   Anemia  Thrombocytopenia Chronic, stable, due to chemotherapy Stable iron and B12 studies in the past Will trend lab   Severe malnutrition poa Nutrition consulted
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Productive cough, Respiratory failure, SARS-CoV-2 test positive, Thrombocytopenia
Clinical narrative: Patient is a 77 y.o. female patient of DO with history of small cell lung cancer on chemotherapy, hyperlipidemia, COPD, hypertension, hypothyroidism, neuropathy and Afib presented to Hospital with generalized weakness and cough.   Generalized weakness S/p Fall  Multifactorial from ongoing cancer chemotherapy (last tx 3 weeks ago) and COVID-19 infection. Having some falls at home Doubt bacterial PNA, but continue antibiotics for now  Had a fall OOB 12/3; no LOC or significant injuries sustained and exam non focal.  Treated with mIVF; encourage adequate PO intake  Consulted PT/OT Doing well 12/6-7 AM   Covid-19 Virus Infection Abnormal CXR, possible CAP Respiratory insufficiency  Date of onset of symptoms: unclear; baseline chronic cough, generalized weakness for 1-2 weeks Symptoms present on admission: Weakness, chronic cough w/ clear phlegm Date of covid positive test: 12/3/22 Vaccination status: vaccinated Imaging: CXR w/ left lung base patchy infiltrate possible pneumonia vs atelectasis  Oxygen requirements on admission: None-- >2L Current oxygen requirements: stable on room air Medical therapy: dexamethasone given 12/3; unclear onset of symptoms, holding remdesivir; continue ceftriaxone/azithromycin for now  Consultants following: e-consult ID to eval for Paxlovid - not a candidate Anticipated special isolation end date: 12/13/2022 U Ag negative; S Cx negative  Wean O2 goal 88-92% Encourage IS/PEP, mucolytics PRN   SCLC w/ mets to adrenals and brain SCLC diagnosed in 12/2021, treated with chemoradiation (carboplatin/etoposide) S/p whole brain radiation in September, currently on lubrinectedin every 3 weeks, due for cycle 3 on 12/5/22 Follows w/ Dr - consulted    COPD Tobacco use Not in acute exacerbation. Recently quit smoking Resume home Spiriva, BD PRN NRT offered, patient declined   Chemotherapy induced peripheral neuropathy Continue gabapentin and B12    Supratherapeutic INR - resolved Hold warfarin, check INR daily INR currently 1.9;   Atrial fibrillation INR 1.9, can resume warfarin per pharmacy Continue metoprolol Elevated BNP likely secondary to Afib than CHF (clinically hypo or euvolemic) Pharmacy to dose warfarin, daily INR  Coumadin managed by PMC AC clinic   HLD Cont statin   Hypothyroidism Cont Synthroid   HTN Resume clonidine and metoprolol   Anemia  Thrombocytopenia Chronic, stable, due to chemotherapy Stable iron and B12 studies in the past Will trend lab   Severe malnutrition poa Nutrition consulted
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure during pregnancy, Headache, Influenza virus test negative
Clinical narrative: My due date is 05/07/2023, so at the time of my vaccination I was about 2 weeks pregnant. I got my influenza vaccine about two days after receiving my COVID-19 booster. They prescribed me low-dose of aspirin for preeclampsia and mesalamine for ulcerative colitis. On 12/21/2022, I started feeling pretty congested and stuffed up but thought it was because of temperatures dropping and possible sinus infection. On 12/23/2022, my congestion was getting progressively worse which became a heavy cough after. On Christmas Day, I went to the hospital because I knew it wasn't a normal pregnancy sinus infection. They tested me for COVID-19, influenza, and RSV for any viral infections; only the COVID-19 test came back positive. They prescribed me an antibiotics azithromycin to help fight potential bronchitis or some bacterial infection my body could be fighting in addition to COVID-19. Right now, I still have some congestion which is causing coughing and phlegm removal from my system. I never developed a fever, my sore throat is gone, and I haven't had a headache since Christmas.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Pre-eclampsia, Productive cough, Respiratory syncytial virus test negative
Clinical narrative: My due date is 05/07/2023, so at the time of my vaccination I was about 2 weeks pregnant. I got my influenza vaccine about two days after receiving my COVID-19 booster. They prescribed me low-dose of aspirin for preeclampsia and mesalamine for ulcerative colitis. On 12/21/2022, I started feeling pretty congested and stuffed up but thought it was because of temperatures dropping and possible sinus infection. On 12/23/2022, my congestion was getting progressively worse which became a heavy cough after. On Christmas Day, I went to the hospital because I knew it wasn't a normal pregnancy sinus infection. They tested me for COVID-19, influenza, and RSV for any viral infections; only the COVID-19 test came back positive. They prescribed me an antibiotics azithromycin to help fight potential bronchitis or some bacterial infection my body could be fighting in addition to COVID-19. Right now, I still have some congestion which is causing coughing and phlegm removal from my system. I never developed a fever, my sore throat is gone, and I haven't had a headache since Christmas.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: My due date is 05/07/2023, so at the time of my vaccination I was about 2 weeks pregnant. I got my influenza vaccine about two days after receiving my COVID-19 booster. They prescribed me low-dose of aspirin for preeclampsia and mesalamine for ulcerative colitis. On 12/21/2022, I started feeling pretty congested and stuffed up but thought it was because of temperatures dropping and possible sinus infection. On 12/23/2022, my congestion was getting progressively worse which became a heavy cough after. On Christmas Day, I went to the hospital because I knew it wasn't a normal pregnancy sinus infection. They tested me for COVID-19, influenza, and RSV for any viral infections; only the COVID-19 test came back positive. They prescribed me an antibiotics azithromycin to help fight potential bronchitis or some bacterial infection my body could be fighting in addition to COVID-19. Right now, I still have some congestion which is causing coughing and phlegm removal from my system. I never developed a fever, my sore throat is gone, and I haven't had a headache since Christmas.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary abnormal, Asthenia, Blood creatinine increased
Clinical narrative: Patient is a 85 y.o. female patient of MD with history of COPD, VTE, chronic pain syndrome, HTN, previous tobacco abuse,  and neuropathy who presented with shortness of breath and found to have COVID. Problem based management in the hospital is as follows:   Acute hypoxic respiratory failure due to Covid-19 Virus Infection COPD with Exacerbation Date of onset of symptoms: 12/7/2022. Date of covid positive test: 12/7/2022 Nonproductive cough, shortness of breath, generalized weakness, body aches and chills Vaccination status: vaccinated x4 CTPA with GGO in bilateral lower>upper lung fields O2 on adm up to  2L NC, now able to be on room air  Normal inflammatory markers.  Initially declined steroids due to GI disturbances but then agreeable as PPI were started together. .  Continued home Symbicort with scheduled and PRN Albuterol inhaler.  ID following.  Continued remdesivir.  Continued prednisone. PT/OT/UM   AKI, resolved Cr 1.29 on arrival. Down to 0.89 on day of discharge Resumed Hyzaar  Monitor renal function Avoid nephrotoxins   Hx of VTE With DVT 2014 and PE 2017 Continued lifelong Eliquis BID   Chronic Pain Syndrome Chronic OA, back pain and trigeminal neuralgia NARx with Percocet 10/325 mg 4x daily and Gabapentin 400 mg q6 hours  HTN resumed Hyzaar as BP elevated  Elevated Troponin TnT 22 on arrival in setting of AKI without CP MPI (6/2021) without inducible ischemia EKG with sinus tachycardic, PVC, artifact, but no ST changes  Depression Stable, continue home Wellbutrin   After 4 days of hospital stay, patient was doing well so she was discharged in stable condition. Advised to f/u with PCP. All questions and concerns were addressed before discharge.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood pressure increased, COVID-19, Chills, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patient is a 85 y.o. female patient of MD with history of COPD, VTE, chronic pain syndrome, HTN, previous tobacco abuse,  and neuropathy who presented with shortness of breath and found to have COVID. Problem based management in the hospital is as follows:   Acute hypoxic respiratory failure due to Covid-19 Virus Infection COPD with Exacerbation Date of onset of symptoms: 12/7/2022. Date of covid positive test: 12/7/2022 Nonproductive cough, shortness of breath, generalized weakness, body aches and chills Vaccination status: vaccinated x4 CTPA with GGO in bilateral lower>upper lung fields O2 on adm up to  2L NC, now able to be on room air  Normal inflammatory markers.  Initially declined steroids due to GI disturbances but then agreeable as PPI were started together. .  Continued home Symbicort with scheduled and PRN Albuterol inhaler.  ID following.  Continued remdesivir.  Continued prednisone. PT/OT/UM   AKI, resolved Cr 1.29 on arrival. Down to 0.89 on day of discharge Resumed Hyzaar  Monitor renal function Avoid nephrotoxins   Hx of VTE With DVT 2014 and PE 2017 Continued lifelong Eliquis BID   Chronic Pain Syndrome Chronic OA, back pain and trigeminal neuralgia NARx with Percocet 10/325 mg 4x daily and Gabapentin 400 mg q6 hours  HTN resumed Hyzaar as BP elevated  Elevated Troponin TnT 22 on arrival in setting of AKI without CP MPI (6/2021) without inducible ischemia EKG with sinus tachycardic, PVC, artifact, but no ST changes  Depression Stable, continue home Wellbutrin   After 4 days of hospital stay, patient was doing well so she was discharged in stable condition. Advised to f/u with PCP. All questions and concerns were addressed before discharge.